No, ozone therapy is not FDA approved. The FDA classifies ozone as a toxic gas with no proven medical application and explicitly states that ozone has no known useful medical purpose in its 2019 regulatory position. Despite this, ozone therapy is legally practiced in the United States under physician discretion in many states, and it is widely used in clinical settings across Europe, Latin America, and Asia.
Key Takeaways
- The FDA classifies ozone as a toxic gas under 21 CFR 801.415 and has not approved it for medical use
- Despite the FDA position, physicians in most states can legally administer ozone therapy under medical practice acts
- No ozone therapy device has received FDA 510(k) clearance for medical treatment
- Ozone is widely accepted in Germany, Italy, Spain, Cuba, Russia, and other countries
- The gap between FDA classification and clinical practice exists because federal regulation and state medical licensing operate independently
What the FDA Actually Says
The FDA’s position on ozone is clear and has remained consistent for decades. Under 21 CFR 801.415, the FDA states:
“Ozone is a toxic gas with no known useful medical application in specific, adjunctive, or preventive therapy. In order for ozone to be effective as a germicide, it must be present in a concentration far greater than that which can be safely tolerated by man and animals.”
This regulation was codified in 1976 and has not been updated since. It means that:
- No pharmaceutical company can market ozone as a drug in the United States
- No medical device manufacturer can sell an ozone generator with FDA clearance for therapeutic use
- Ozone cannot be advertised or labeled as a treatment for any medical condition
It is worth noting that the FDA’s classification dates from an era before much of the modern ozone therapy research was published. The regulatory position has not evolved alongside the growing body of clinical literature.
Why Ozone Therapy Is Still Legally Practiced
This is the part that confuses most people. If the FDA says ozone has no medical use, how are clinics openly offering it?
The answer lies in how medical regulation works in the United States. The FDA regulates drugs and devices. It does not regulate the practice of medicine. Licensed physicians can use their clinical judgment to employ treatments they believe will benefit their patients, even if those treatments are not FDA approved, as long as they:
- Hold a valid medical license in their state
- Obtain informed consent from the patient
- Do not make fraudulent claims
- Operate within their state’s medical practice act
This is the same principle that allows physicians to prescribe FDA-approved drugs for off-label uses, which accounts for approximately 20% of all prescriptions written in the US. Ozone therapy falls into a similar gray area: not approved, but not prohibited for licensed physicians.
“The FDA’s 1976 classification of ozone predates the majority of modern clinical research on ozone therapy. The regulatory framework has simply not kept pace with the science.”
State-by-State Legal Status
While federal regulation sets the FDA’s position, actual enforcement and permissibility of ozone therapy varies by state. Some states have explicit protections for alternative medicine practitioners, while others have pursued enforcement actions.
| Category | States | Status |
|---|---|---|
| Explicitly protective | Alaska, Arizona, Colorado, Nevada, New York, Oklahoma, Oregon, Texas, Washington | Medical freedom or integrative medicine statutes protect physicians using ozone |
| Generally permissive | California, Florida, Georgia, Massachusetts, Ohio, Pennsylvania | No specific restrictions. Physicians practice ozone under general medical license |
| Restrictive or unclear | A handful of states have pursued disciplinary actions against ozone practitioners | Risk of medical board scrutiny in states without protective legislation |
States with “health freedom” or “medical freedom” laws generally provide the strongest protections. These laws were specifically designed to protect physicians who practice integrative, complementary, or alternative medicine from losing their licenses solely for using non-conventional treatments.
International Acceptance
The FDA’s position on ozone therapy is increasingly an outlier compared to regulatory bodies in other countries.
| Country | Status | Notes |
|---|---|---|
| Germany | Widely practiced and regulated | Over 10,000 practitioners. German Medical Society for Ozone Therapy active since 1972 |
| Italy | Regulated medical treatment | SIOOT (Italian Society of Oxygen-Ozone Therapy) provides training and standards |
| Spain | Practiced in clinical settings | AEPROMO provides accreditation and research coordination |
| Cuba | Integrated into public health system | National Center for Ozone Research established 1990s. Used in hospitals |
| Russia | Approved medical treatment | Ministry of Health approved since 2001. Used in over 200 hospitals |
| India | Growing clinical use | Not formally regulated but widely practiced in integrative medicine |
| Brazil | Approved by Federal Council of Medicine | Resolution CFM 2.181/2018 approved ozone as experimental medical procedure |
The Research vs. Regulation Gap
One of the central tensions in the ozone therapy landscape is the growing disconnect between clinical research and regulatory status in the US.
As of 2025, PubMed indexes over 3,500 published papers on ozone therapy. These include randomized controlled trials, systematic reviews, and meta-analyses covering conditions from herniated discs to diabetic wound healing to chronic infections. The International Scientific Committee of Ozone Therapy (ISCO3) maintains a comprehensive database of clinical evidence and has published treatment guidelines adopted in multiple countries.
Key research milestones include:
- Multiple RCTs demonstrating efficacy for lumbar disc herniation (Gallucci et al., 2007; Magalhaes et al., 2012)
- Systematic reviews supporting ozone for chronic wound healing (Fitzpatrick et al., 2018)
- Clinical trials showing improved glycemic control in diabetic patients (Martínez-Sánchez et al., 2005)
- Safety data from over 5 million treatment sessions in Germany showing a complication rate of 0.0007% (Jacobs, 1982)
Despite this evidence, no pharmaceutical company or device manufacturer has pursued FDA approval. The primary reason is economic: ozone cannot be patented, so there is no financial incentive to fund the large-scale Phase III clinical trials the FDA requires for drug approval. This same dynamic affects other non-patentable therapies like hyperbaric oxygen therapy for off-label conditions.
Ongoing FDA Enforcement
The FDA periodically takes enforcement action against companies marketing ozone generators or ozone-based products with medical claims. Recent actions include:
- Warning letters to manufacturers of home ozone generators marketed for health purposes
- Seizure of ozone-generating devices sold with therapeutic claims
- Warning letters to clinics advertising ozone as a treatment for COVID-19 during the pandemic
These enforcement actions target marketing claims and device labeling, not the practice of medicine by licensed physicians. A physician administering ozone therapy in their office is in a different regulatory category than a company selling ozone machines to consumers with health claims.
What This Means for Patients
The lack of FDA approval has several practical implications for patients considering ozone therapy:
- Insurance coverage: Because ozone therapy is not FDA approved, health insurance plans do not cover it. All costs are out of pocket
- Provider accountability: Without FDA oversight, the quality of ozone therapy varies significantly between providers. There is no standardized training requirement or certification mandate
- Informed consent: Reputable clinics will clearly disclose the FDA’s position and require signed informed consent before treatment
- Research access: Patients can access ozone therapy through clinical trials registered on ClinicalTrials.gov, which may provide treatment at reduced or no cost
The Bottom Line
Ozone therapy is not FDA approved, and the FDA’s position (codified in 1976) classifies ozone as a toxic gas with no proven medical use. However, this does not make ozone therapy illegal. Licensed physicians in most states can legally administer it under their medical practice authority, and it is widely used and regulated in many other countries. The gap between FDA classification and clinical practice reflects the difficulty of obtaining regulatory approval for a non-patentable substance, not necessarily a lack of clinical evidence.
References
- U.S. Food and Drug Administration. (1976). 21 CFR 801.415 – Maximum acceptable level of ozone. Code of Federal Regulations.
- Gallucci, M., et al. (2007). Sciatica: Treatment with intradiscal and intraforaminal injections of steroid and oxygen-ozone. Interventional Neuroradiology, 13(4), 409-416. DOI: 10.1177/159101990701300409
- Magalhaes, F. N., et al. (2012). Ozone therapy as a treatment for low back pain secondary to herniated disc. Pain Physician, 15(2), E115-E129. DOI: 10.36076/ppj.2012/15/E115
- Fitzpatrick, E., et al. (2018). Ozone therapy for chronic wounds. International Journal of Environmental Research and Public Health, 15(7), 1036. DOI: 10.3390/ijerph15071036
- Martínez-Sánchez, G., et al. (2005). Therapeutic efficacy of ozone in patients with diabetic foot. European Journal of Pharmacology, 523(1-3), 151-161.
- Jacobs, M. T. (1982). Adverse effects and typical complications in ozone-oxygen therapy. OzoNachrichten, 1, 5-7.
- ISCO3 (International Scientific Committee of Ozone Therapy). (2020). Madrid Declaration on Ozone Therapy (3rd edition).
Medical Disclaimer
The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Author
Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.
